Kosuke Robert Shima (Kosuke R Shima)

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Placebo Controlled

Cardiovascular Disease

Top Venues

Journal of diabetes investigation

BMJ open diabetes research & care

This page only lists publications with an associated author ORCID identifier.

Publications

Atsushi Tanaka, Michio Shimabukuro, Noritaka Machii, Hiroki Teragawa, Yosuke Okada, Kosuke Robert Shima, Toshinari Takamura, Isao Taguchi, Itaru Hisauchi, Shigeru Toyoda, Yasushi Matsuzawa, Hirofumi Tomiyama, Minako Yamaoka-Tojo, Shinichiro Ueda, Yukihito Higashi, Koichi Node
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial. Journal of diabetes investigation 11 (6) (2020)
Atsushi Tanaka, Michio Shimabukuro, Noritaka Machii, Hiroki Teragawa, Yosuke Okada, Kosuke Robert Shima, Toshinari Takamura, Isao Taguchi, Itaru Hisauchi, Shigeru Toyoda, Yasushi Matsuzawa, Hirofumi Tomiyama, Minako Yamaoka-Tojo, Hisako Yoshida, Yasunori Sato, Yumi Ikehara, Shinichiro Ueda, Yukihito Higashi, Koichi Node, null null
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial. Diabetes care 42 (10) (2019)
Kosuke Robert Shima, Tsuguhito Ota, Ken-Ichiro Kato, Yumie Takeshita, Hirofumi Misu, Shuichi Kaneko, Toshinari Takamura
Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study. BMJ open diabetes research & care 6 (1) (2018)